# The Imperial Comprehensive Cognitive Assessment in Cerebrovascular Disease (IC3)

> **NCT05885295** · — · RECRUITING · sponsor: **Imperial College London** · enrollment: 700 (estimated)

## Conditions studied

- Stroke
- Stroke (CVA) or TIA
- Dementia, Vascular
- Cerebrovascular Disorders
- Small Vessel Cerebrovascular Disease
- Cognitive Impairment

## Interventions

- **DIAGNOSTIC_TEST:** MRI brain, Blood tests, cognitive assessments

## Key facts

- **NCT ID:** NCT05885295
- **Lead sponsor:** Imperial College London
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2021-12-01
- **Primary completion:** 2028-05-15
- **Final completion:** 2028-05-15
- **Target enrollment:** 700 (ESTIMATED)
- **Last updated:** 2023-06-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05885295

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05885295, "The Imperial Comprehensive Cognitive Assessment in Cerebrovascular Disease (IC3)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05885295. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*